Clostridium difficile: Difference between revisions

Line 28: Line 28:


===Harbor Testing Algorithm===
===Harbor Testing Algorithm===
#Patient with suspected Clostridium difficile associated diarrhea (CDAD)
*Patient with suspected Clostridium difficile associated diarrhea (CDAD)
##'''Low''' suspicion for CDAD
**'''Low''' suspicion for CDAD
###Send stool for C. diff toxin assay
***Send stool for C. diff toxin assay
####Positive --> treat (no further testing indicated)
****Positive --> treat (no further testing indicated)
####Negative --> do not treat (no further testing indicated)
****Negative --> do not treat (no further testing indicated)
##'''High''' suspicion for CDAD
**'''High''' suspicion for CDAD
###Send stool for C. diff toxin assay AND treat empirically
***Send stool for C. diff toxin assay AND treat empirically
####Positive --> treat (no further testing indicated)
****Positive --> treat (no further testing indicated)
####Negative --> Consider discussion with ID (false negative tests may occur); eval for other causes of diarrhea
****Negative --> Consider discussion with ID (false negative tests may occur); eval for other causes of diarrhea


*Repeat testing
*Repeat testing

Revision as of 18:18, 4 June 2015

Background

  • Most common cause of infectious diarrhea in hospitalized pts
  • Use contact isolation if suspect
  • Alcohol-based hand sanitizers does not reduce spore, but good hand washing does[1]
  • Risk factors for pseudomembranous colitis:
    • Recent abx use (any)
    • GI surgery
    • Severe underlying medical illness
    • Chemo
    • Elderly
  • 60-70% of infants are asymptomatic carriers of c diff[2]

Diagnosis

History

  • Diarrhea that develops during abx use or w/in 2wk of discontinuation
  • Recent discharge from hospital
  • Profuse watery diarrhea

Exam

  • Abdominal pain
  • Fever
  • Leukocytosis
  • +Fecal leukocytes (distinguishes from benign forms of abx-induced diarrhea)

Labs

  • C. diff toxin assay
    • Sn 63-94%, Sp 75-100%
  • Culture
    • Positve culture only means C. diff present, not necessarily that it is causing disease

Harbor Testing Algorithm

  • Patient with suspected Clostridium difficile associated diarrhea (CDAD)
    • Low suspicion for CDAD
      • Send stool for C. diff toxin assay
        • Positive --> treat (no further testing indicated)
        • Negative --> do not treat (no further testing indicated)
    • High suspicion for CDAD
      • Send stool for C. diff toxin assay AND treat empirically
        • Positive --> treat (no further testing indicated)
        • Negative --> Consider discussion with ID (false negative tests may occur); eval for other causes of diarrhea
  • Repeat testing
    • Never a need for repeat testing within 7 days of a previous test
    • NO NEED to repeat positive tests as symptoms resolve as a “test of cure”
    • NO NEED to repeat test soon after initial negative test (more likely to be a false positive test than a true positive test)

Treatment

Asymptomatic

  • No diagnostic testing or treatment required[3]

Mild

  • Either discontinue offending antibiotics(if possible) or give Metronidazole 500mg PO q6hr x10-14d

Moderate

  • Vancomycin 125 mg PO four times daily for 10 days
  • Fidaxomicin 200 mg PO two times daily for 10 days
  • Metronidazole 500mg PO or IV four times daily for 10 days (third line therapy)

Severe

Criteria:[4][5]

  • Serum lactate levels >2.2 mmol/l
  • Hypotension with or without required use of vasopressors
  • Ileus or significant abdominal distention
  • Mental status changes
  • WBC ≥35,000 cells/mm3 or <2,000 cells/mm3
  • Patient requiring ICU admission
  • End organ failure (mechanical ventilation, renal failure, etc.)

Treatment:

  • Vancomycin 125 mg PO four times daily for 10 days
  • Fidaxomicin 200 mg PO two times daily for 10 days
  • Emergency colectomy should be considered if:
    • WBC >20K
    • Lactate >5
    • Age >75
    • Immunosuppression
    • Toxic megacolon
    • Colonic perforation
    • Multi-organ system failure

Recurrent Infection

  1. Occurs <=4 weeks after the completion of therapy
    1. Otherwise consider other (more common) causes
  2. Antimicrobial resistance is not clinically problematic, first recurrence treated with the same agent used to treat the initial episode

Antibiotic Sensitivities[6]

Category Antibiotic Sensitivity
Penicillins Penicillin G X2
Penicillin V X1
Anti-Staphylocccal Penicillins Methicillin X1
Nafcillin/Oxacillin X1
Cloxacillin/Diclox. X1
Amino-Penicillins AMP/Amox X1
Amox-Clav X1
AMP-Sulb X2
Anti-Pseudomonal Penicillins Ticarcillin X1
Ticar-Clav X1
Pip-Tazo X1
Piperacillin X2
Carbapenems Doripenem X2
Ertapenem X2
Imipenem X2
Meropenem X2
Aztreonam R
Fluroquinolones Ciprofloxacin R
Ofloxacin X1
Pefloxacin X1
Levofloxacin R
Moxifloxacin R
Gemifloxacin X1
Gatifloxacin R
1st G Cephalo Cefazolin X1
2nd G. Cephalo Cefotetan X1
Cefoxitin R
Cefuroxime X1
3rd/4th G. Cephalo Cefotaxime R
Cefizoxime R
CefTRIAXone X1
Ceftaroline X1
CefTAZidime X1
Cefepime R
Oral 1st G. Cephalo Cefadroxil X1
Cephalexin X1
Oral 2nd G. Cephalo Cefaclor/Loracarbef X1
Cefproxil X1
Cefuroxime axetil X1
Oral 3rd G. Cephalo Cefixime X1
Ceftibuten X1
Cefpodox/Cefdinir/Cefditoren X1
Aminoglycosides Gentamicin R
Tobramycin R
Amikacin R
Chloramphenicol I
Clindamycin X1
Macrolides Erythromycin X1
Azithromycin X1
Clarithromycin X1
Ketolide Telithromycin X1
Tetracyclines Doxycycline X1
Minocycline X1
Glycylcycline Tigecycline X1
Daptomycin X1
Glyco/Lipoclycopeptides Vancomycin S
Teicoplanin S
Telavancin S
Fusidic Acid X1
Trimethoprim X1
TMP-SMX X1
Urinary Agents Nitrofurantoin X1
Fosfomycin X1
Other Rifampin X1
Metronidazole S
Quinupristin dalfoppristin I
Linezolid I
Colistimethate X1

Disposition

  • Admit:
    • Severe diarrhea
    • Oupt abx failure
    • Systemic response (fever, leukocytosis, severe abdominal pain)

References

  1. Leffler DA and Lamont JT. Clostridium difficile Infection. N Engl J Med. 2015; 372:1539-1548.
  2. Jangi S and Lamon JT. Asymptomatic colonization by Clostridium difficile: implications for disease in later life. J Pediatr Gastroenterol Nutr. 2010; 51(1):2-7.
  3. Bagdasarian, N, et al. Diagnosis and Treatment of Clostridium difficile in Adults. JAMA. 2015; 313(4):398-408.
  4. IDSA Guidelines PDF
  5. ACG Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections http://gi.org/guideline/diagnosis-and-management-of-c-difficile-associated-diarrhea-and-colitis/
  6. Sanford Guide to Antimicrobial Therapy 2014

See Also